UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice

EMBO molecular medicine, 2014-10, Vol.6 (10), p.1246-1262

2014

Volltextzugriff (PDF)

A critical role for IGF-II in memory consolidation and enhancement

Nature (London), 2011-01, Vol.469 (7331), p.491-497

2011

Volltextzugriff (PDF)

Amyloid Beta Mediates Memory Formation

Learning & memory (Cold Spring Harbor, N.Y.), 2009-04, Vol.16 (4), p.267-272

2009

Volltextzugriff (PDF)

Resveratrol Protects against Sepsis-Associated Encephalopathy and Inhibits the NLRP3/IL-1β Axis in Microglia

Mediators of Inflammation, 2016-01, Vol.2016 (2016), p.12-21-001

2016

Volltextzugriff (PDF)

Decreased levels of guanosine 3′, 5′-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

Neuropathology and applied neurobiology, 2015-06, Vol.41 (4), p.471-482

2015

Volltextzugriff (PDF)

Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition

Mediators of Inflammation, 2015-01, Vol.2015 (2015), p.907-923-485

2015

Volltextzugriff (PDF)

PLA2G4E AS AN ESSENTIAL PROTEIN FOR PROPER SYNAPTIC FUNCTION AND BRAIN DEVELOPMENT

IBRO neuroscience reports, 2023-10, Vol.15, p.S297-S297

2023

Volltextzugriff (PDF)

Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease

Hippocampus, 2012-05, Vol.22 (5), p.1040-1050

2012

Volltextzugriff (PDF)

CROSS-TALK BETWEEN NEUROMELANIN AND SYNUCLEIN IN PARKINSON’S DISEASE

IBRO neuroscience reports, 2023-10, Vol.15, p.S410-S411

2023

Volltextzugriff (PDF)

Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer's Disease

Frontiers in aging neuroscience, 2019-06, Vol.11, p.149-149

2019

Volltextzugriff (PDF)

Phenylbutyrate Ameliorates Cognitive Deficit and Reduces Tau Pathology in an Alzheimer's Disease Mouse Model

Neuropsychopharmacology (New York, N.Y.), 2009-06, Vol.34 (7), p.1721-1732

2009

Volltextzugriff (PDF)

Docosahexaenoic Acid Ameliorates Contextual Fear Memory Deficits in the Tg2576 Alzheimer's Disease Mouse Model: Cellular and Molecular Correlates

Pharmaceutics, 2022-12, Vol.15 (1), p.82

2022

Volltextzugriff (PDF)

Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice

Journal of Alzheimer's disease, 2012-01, Vol.28 (3), p.567-578

2012

Volltextzugriff (PDF)

p27, The Cell Cycle and Alzheimer´s Disease

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1211

2022

Volltextzugriff (PDF)

Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease

ACS chemical neuroscience, 2012-11, Vol.3 (11), p.832-844

2012

Volltextzugriff (PDF)

Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD

Neuropharmacology, 2013-01, Vol.64, p.114-123

2013

Volltextzugriff (PDF)

Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy

Molecular therapy. Nucleic acids, 2019-06, Vol.16, p.26-37

2019

Volltextzugriff (PDF)

Disrupting the memory of places induced by drugs of abuse weakens motivational withdrawal in a context-dependent manner

Proceedings of the National Academy of Sciences - PNAS, 2010-07, Vol.107 (27), p.12345-12350

2010

Volltextzugriff (PDF)

Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer’s Disease

International journal of molecular sciences, 2021-09, Vol.22 (17), p.9120

2021

Volltextzugriff (PDF)

GLUT12 Expression in Brain of Mouse Models of Alzheimer’s Disease

Molecular neurobiology, 2020-02, Vol.57 (2), p.798-805

2020

Volltextzugriff (PDF)

Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels

Journal of neurochemistry, 2016-01, Vol.136 (2), p.403-415

2016

Volltextzugriff (PDF)

Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer's Disease

International journal of molecular sciences, 2021-11, Vol.22 (21), p.11950

2021

Volltextzugriff (PDF)

The immune system: uncharted pathways between senses and the brain

Neural regeneration research, 2024-06, Vol.19 (6), p.1173-1174

2024

Volltextzugriff (PDF)

Advanced Assay Monitoring APP-Carboxyl-Terminal Fragments as Markers of APP Processing in Alzheimer Disease Mouse Models

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1303, p.117

2016

Volltextzugriff (PDF)

Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer´s disease-like phenotype of a commonly used mouse model

Current pharmaceutical design, 2013, Vol.19 (28), p.5076-5084

2013

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(71)
Dissertationen
(1)

Sprache

Englisch
(71)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice

A critical role for IGF-II in memory consolidation and enhancement

Amyloid Beta Mediates Memory Formation

Resveratrol Protects against Sepsis-Associated Encephalopathy and Inhibits the NLRP3/IL-1β Axis in Microglia

Decreased levels of guanosine 3′, 5′-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition

PLA2G4E AS AN ESSENTIAL PROTEIN FOR PROPER SYNAPTIC FUNCTION AND BRAIN DEVELOPMENT

Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease

CROSS-TALK BETWEEN NEUROMELANIN AND SYNUCLEIN IN PARKINSON’S DISEASE

Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer's Disease

Phenylbutyrate Ameliorates Cognitive Deficit and Reduces Tau Pathology in an Alzheimer's Disease Mouse Model

Docosahexaenoic Acid Ameliorates Contextual Fear Memory Deficits in the Tg2576 Alzheimer's Disease Mouse Model: Cellular and Molecular Correlates

Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice

p27, The Cell Cycle and Alzheimer´s Disease

Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease

Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD

Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy

Disrupting the memory of places induced by drugs of abuse weakens motivational withdrawal in a context-dependent manner

Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer’s Disease

GLUT12 Expression in Brain of Mouse Models of Alzheimer’s Disease

Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels

Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer's Disease

The immune system: uncharted pathways between senses and the brain

Advanced Assay Monitoring APP-Carboxyl-Terminal Fragments as Markers of APP Processing in Alzheimer Disease Mouse Models

Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer´s disease-like phenotype of a commonly used mouse model

Suchergebnisse filtern